Stock Screener App

無料 -

インストール

7.35

1.10% 0.08

Decoy Therapeutics Inc (DCOY)

概要ニュース株価時系列ディスカッション予測

Decoy Therapeutics Inc (DCOY) 最新ニュース

Nabriva Therapeutics (NASDAQ:NBRV) and Decoy Therapeutics (NASDAQ:DCOY) Head to Head Survey - Defense World

If You Invested $1,000 in Salarius Pharmaceuticals Inc (SLRX) - Stock Titan

Decoy Therapeutics Inc.: Fundamental Analysis and Financial Ratings | | US79400X6022 - marketscreener.com

Decoy Therapeutics Inc.: Fundamental Analysis and Financial Ratings | FP11 | US79400X6022 - marketscreener.com

Decoy Therapeutics partners with Quantori on AI peptide platform By Investing.com - Investing.com Nigeria

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - Lelezard

Decoy Therapeutics Inc. Earnings and Revenue – GETTEX:FP11 - TradingView

Debt to equity ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

EBIT per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Price to cash flow ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Free cash flow per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Net margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Revenue per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Operating margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Net current asset value per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Enterprise value to EBITDA ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Non-controlling/minority interest of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Price to book ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Total operating expenses of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

CapEx per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Equity in earnings of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

EBIT of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Total debt per share of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Debt to assets ratio of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Total common shares outstanding of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Operating income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Enterprise value of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

EBITDA margin % of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Discontinued operations of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Decoy Therapeutics Inc. Statistics – GETTEX:FP11 - TradingView

Gross profit of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Taxes of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Preferred dividends of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Diluted shares outstanding of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

After tax other income/expense of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Diluted net income available to common stockholders of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Pretax income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Net income of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Non-operating income (total) of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

EBITDA of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Free float of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Decoy Therapeutics Inc. Revenue Breakdown – GETTEX:FP11 - TradingView

Number of employees of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Decoy Therapeutics (DCOY) Partners with Quantori to Enhance Anti - GuruFocus

Decoy Therapeutics partners with Quantori on AI peptide platform - Investing.com

Decoy Therapeutics enters collaboration with Quantori - TipRanks

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform – NEWSnet Michigan - michigan.newsnetmedia.com

Google Cloud-funded AI aims up to 100-fold faster antiviral peptide design - Stock Titan

Decoy Therapeutics Inc. Revenue Breakdown – MUN:FP11 - TradingView

Decoy Therapeutics Inc. Earnings and Revenue – MUN:FP11 - TradingView

Free cash flow of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Total equity of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Total assets of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Total liabilities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Cash from financing activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Cash from operating activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Total debt of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Cash from investing activities of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Decoy Therapeutics (FRA:FP11) Shiller PE Ratio : (As of Mar. 11, 2026) - GuruFocus

Debt to assets ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Net margin % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

CapEx per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

EBITDA per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Long term debt to total equity ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Current ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Return on invested capital % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Gross margin % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Book value per share of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Total common shares outstanding of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Price to book ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Price to cash flow ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Debt to equity ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く